Dr. Robinson is Professor Emeritus at the University of Iowa in Iowa City. She has a medical degree and a Master's degree in Public Health from the University of Minnesota.
Dr. Robinson has published over 200 peer-reviewed articles in the area of lipid-modifying drugs, cardiovascular risk stratification, and cardiovascular prevention, with multiple recent publications in The New England Journal of Medicine and Journal of the American Medical Association. Dr. Robinson has researched a wide range of anti-atherosclerotic and metabolic agents, including lipid-modifying, anti-inflammatory, antihypertensive, weight loss, and diabetic treatments, as well as postmenopausal hormone therapy. She has also lectured widely on preventive cardiology and the diagnosis and treatment of disorders of lipid metabolism.
Dr. Robinson has served in leadership roles in multiple American Heart Association committees and was Vice-Chair for the American Heart Association/American College of Cardiology Cholesterol Guidelines. She was also a member of the American Heart Association/American College of Cardiology Risk Reduction Guidelines.
Financial Disclosures
The author has not disclosed any financial relationships.
Source: Content for this module was reproduced with permission from: Robinson JG. Clinical Lipid Management, 2nd ed. Professional Communications Inc. 2023. All rights reserved.
